The shares closed at $6.24 on Thursday as the Nasdaq Composite gained 0.89% to 24,892.31 and the Dow rose 1.62% to 49,652.14.
Tilray outperformed the broader market during a strong session for equities, ending its recent slide after two consecutive daily declines.
Despite the rebound, the stock remains 73.10% below its 52-week high of $23.20 reached on 9 October, while trading volume of 4.5 million was slightly below its 50-day average.
Cannabis rescheduling is a historic win, but can Tilray’s CPG pivot finally lead the company to sustained profitability?
As Tilray eyes U.S. expansion, can it thrive in a market where massive oversupply is crushing thousands of existing businesses?